AxoGen Inc. Expected to Post Q1 2018 Earnings of $0.01 Per Share (AXGN)
AxoGen Inc. (NASDAQ:AXGN) – Lake Street Capital issued their Q1 2018 earnings per share (EPS) estimates for shares of AxoGen in a note issued to investors on Wednesday. Lake Street Capital analyst B. Jackson expects that the firm will post earnings per share of $0.01 for the quarter. Lake Street Capital currently has a “Buy” rating and a $11.00 target price on the stock. Lake Street Capital also issued estimates for AxoGen’s Q2 2018 earnings at $0.03 EPS and Q3 2018 earnings at $0.04 EPS.
Other research analysts have also recently issued reports about the stock. Wedbush restated an “outperform” rating and set a $12.00 price target on shares of AxoGen in a report on Friday. JMP Securities reiterated a “buy” rating on shares of AxoGen in a research note on Tuesday.
Shares of AxoGen (NASDAQ:AXGN) traded up 0.57% on Thursday, reaching $8.80. 111,646 shares of the company were exchanged. AxoGen has a 12-month low of $4.52 and a 12-month high of $9.88. The stock’s market capitalization is $289.50 million. The firm has a 50 day moving average price of $8.68 and a 200-day moving average price of $7.66.
AxoGen (NASDAQ:AXGN) last announced its quarterly earnings data on Wednesday, November 2nd. The company reported ($0.08) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.08). AxoGen had a negative net margin of 33.02% and a negative return on equity of 292.94%.
In related news, CEO Karen L. Zaderej bought 10,000 shares of the company’s stock in a transaction on Friday, October 7th. The shares were purchased at an average cost of $7.50 per share, for a total transaction of $75,000.00. Following the completion of the purchase, the chief executive officer now directly owns 242,147 shares in the company, valued at $1,816,102.50. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. Also, VP John P. Engels bought 4,000 shares of the company’s stock in a transaction on Friday, October 7th. The stock was bought at an average price of $7.50 per share, for a total transaction of $30,000.00. Following the completion of the purchase, the vice president now owns 98,425 shares of the company’s stock, valued at $738,187.50. The disclosure for this purchase can be found here. 9.33% of the stock is currently owned by company insiders.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in AXGN. BlackRock Fund Advisors boosted its position in AxoGen by 1,049.1% in the second quarter. BlackRock Fund Advisors now owns 634,132 shares of the company’s stock worth $4,363,000 after buying an additional 578,948 shares during the last quarter. Vanguard Group Inc. boosted its position in AxoGen by 61.5% in the second quarter. Vanguard Group Inc. now owns 775,448 shares of the company’s stock worth $5,335,000 after buying an additional 295,294 shares during the last quarter. State Street Corp bought a new position in AxoGen during the second quarter worth $1,885,000. Summit Partners Public Asset Management LLC bought a new position in AxoGen during the third quarter worth $2,376,000. Finally, Waddell & Reed Financial Inc. bought a new position in AxoGen during the second quarter worth $1,371,000. Hedge funds and other institutional investors own 54.43% of the company’s stock.
Receive News & Stock Ratings for AxoGen Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AxoGen Inc. and related stocks with our FREE daily email newsletter.